Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (39)
  • 2025 (17)

Subject

  • Drug Trafficking (1305)
  • Synthetic drugs (450)
  • Arrests/Convictions - Major (368)
  • Guns/Weapons (326)
  • Fake Pills (273)
  • OCDETF/Task Force (191)
  • Seizures (Drugs/Property) (191)
  • Guilty Plea (181)
  • Fentanyl Free America (142)
  • Fentanyl Awareness (136)
  • Prescription Drugs (107)
  • Counterfeit Pills (104)
  • Task Forces/Task Force Officers (98)
  • Diversion Division (92)
  • Major Law Enforcement Operation (91)
  • Money Laundering (74)
  • Outreach/Drug Prevention (69)
  • Overdose (69)
  • Take Back Day (63)
  • One Pill Can Kill (55)
  • Gangs (53)
  • HIDTA (32)
  • Campaigns (29)
  • Other (29)
  • Cartel (28)
  • Press Conferences (23)
  • Extraditions (22)
  • Narcoterrorism (22)
  • Prevention/Education - DEA websites GSAD, JTT etc (20)
  • Terrorism (11)
  • International/Foreign Operations (10)
  • Public and Media Affairs - also see Congressional Affairs (10)
  • Dark Web- Internet Trafficking (7)
  • Critical Incident (5)
  • Asset Forfeiture (4)
  • Intelligence Division - Intelligence Products (4)
  • Museum and Visitors Center (2)
  • Red Ribbon (2)
  • Pharmaceuticals/Pharmacists/Physicians (53)
  • Intergovernmental Affairs (2)
  • Forensics: Quality Management System Documents (1)

Drug Name

  • Oxycodone (6)
  • Fentanyl (4)
  • Hydromorphone (4)
  • Benzodiazepines (1)
  • Methamphetamine (1)
  • Morphine (1)
  • Opioids (1)

Field Division

  • Atlanta (3)
  • Caribe (1)
  • El Paso (5)
  • Louisville (8)
  • Miami (4)
  • New England (1)
  • New Jersey (2)
  • New York (4)
  • Omaha (2)
  • Phoenix (2)
  • Rocky Mountain (1)
  • San Francisco (7)
  • Seattle (3)
  • Sede (4)
  • St. Louis (7)
  • Tampa (1)
  • Washington, DC (1)
Clear All Results
View Archived Press Releases
56 Results - Showing 1 to 10
PRESS RELEASE

DEA Highlights the Integral Role of Forensic Science in Addressing the Synthetic Drug Crisis

SAN FRANCISCO — As synthetic drugs continue to evolve and threaten American lives, DEA chemists and forensic science professionals play an essential role in helping the U.S. Drug Enforcement Administration identify emerging threats, connect evidence to investigations, and provide timely information that can save lives. From analyzing suspected fentanyl and...
PRESS RELEASE

Fort Walton Beach Physician Pays $300,000 To Resolve Controlled Substances Act Violation Allegations

Pensacola, Fla. – Dr. Twan Phanijphand, M.D., a gastroenterologist located in Fort Walton Beach, Fla., agreed to pay $300,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances in violation of the Controlled Substances Act (CSA). As part of the settlement, Dr. Phanijphand also agreed to not...
PRESS RELEASE

HSTF Investigation Leads to Criminal Indictment of Prominent Pill Press Company and Arrest of Principal Managers

TUCSON, Ariz. – On Sep. 9, 2026, Special Agents of the Drug Enforcement Administration, Tucson District Office, conducted a multi-state enforcement operation resulting in the arrest of Alastair Mark Sanderson, 39, of Overland Park, Kansas; William Robert Norris, 43, of Westworth Village, Texas; and Michael Christian Packard, 36, of Fort...
PRESS RELEASE

Pharmacist Charged With Drug Diversion From National Pharmacy Chain

BOSTON – A Pittsfield pharmacist has been charged in federal court in Boston with allegedly diverting Adderall and Dextroamp-amphetamin (generic Adderall) from a national pharmacy chain. Joshua Bradley, 30, of Pittsfield, was charged with five counts of acquiring a controlled substance by fraud, deception and subterfuge. The defendant will make...
PRESS RELEASE

40th International Drug Enforcement Conference Focuses on Justice through Strength and Unity

BUENOS AIRES, Argentina – The U.S. Drug Enforcement Administration and Argentina’s Ministry of National Security concluded the 40th annual International Drug Enforcement Conference (IDEC) last week, bringing together more than 500 senior drug enforcement officials and delegates from 110 countries to strengthen global cooperation in the fight against transnational drug...
PRESS RELEASE

Veterans Affairs Nurse Indicted for Stealing Opioids

MINNEAPOLIS – United States Attorney Daniel N. Rosen announced that Steve Michael Kelley, 58, a former nurse who worked at the Veterans Affairs Medical Center in Minneapolis, was indicted by grand jury for one count of obtaining controlled substances by misrepresentation, fraud, forgery, deception, or subterfuge. His initial appearance was...
PRESS RELEASE

Alleged Mexico-Based MethTrafficker Transported Back to the United States to Face Federal Charges

OAKLAND – The government of Mexico recently deported Julio Palafox, a United States citizen, to the United States where he was arrested by the United States Marshals on a warrant to appear on charges stemming from his alleged involvement in the distribution of methamphetamine in the Bay Area. U.S. Marshals...
PRESS RELEASE

United States Reaches $4.17 Million Civil Settlement and Three-Year Compliance Agreement with West Virginia University Health System Over Controlled Substance Violations

WHEELING, Wv. — The United States Attorney’s Offices for the Northern and Southern Districts of West Virginia announced today that West Virginia United Health System, Inc., doing business as West Virginia University Health System (WVUHS), has agreed to pay $4,177,139 and enter a Memorandum of Agreement to resolve civil allegations...
PRESS RELEASE

Former Nurse Loses License After Forging Prescriptions for Percocet and Oxycodone Using Coworker’s Pad

KANSAS CITY, KAN. – A Missouri woman’s crimes to get illegal access to prescription narcotics resulted in the loss of her nursing license and gained her a lifetime ban from working at any hospital that receives federal funding. According to court documents, Brooke Haller, 41, of Kansas City, Missouri, pleaded...
PRESS RELEASE

Orlando Pharmacy and Pharmacist Agree to Pay $50,000 to Settle Controlled Substances Act Violations

Orlando, FL – Plaza Pharmacy, LLC and Paul Ezeobinwa have agreed to pay the United States $50,000 to resolve allegations that they violated the Controlled Substances Act by improperly distributing schedule V drugs and committing multiple recordkeeping violations. U.S. Attorney Gregory W. Kehoe made the announcement. “Our Diversion investigators will...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster